XYNOS KONSTANTINOS (Chief Medical Officer) sold 4.9% of their position (11.45K shares) of REPLIMUNE GROUP, INC. on the open market
Open‑market sale worth $148.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/12/2026ACC: 0001104659-26-095006
Officer· Chief Medical Officer
Since Dec 2022
-11.45K
Net shares
Net seller
$148.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.45K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.45K
Price / share
$12.97
Trade value
$148.47K
% of position
4.9%
8/10/2026
235.66K→224.22K
Total
Net shares
−11.45K
Net value
-$148.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | S · Sale | −11.45K | $12.97 | $148.47K | 4.9% | 235.66K | 224.22K |
| Total | −11.45K | -$148.47K | ||||||
Derivative Transactions0
No derivative transactions reported